Covid-19 vaccine by Arcturus and Singapore’s Duke-NUS in phase 2 trials
SINGAPORE – Three different Covid-19 messenger RNA vaccines which may have reduced side effects when administered are being developed with Singapore’s involvement in their clinical trials. Developed by United States-firm […]